返回
Cynata Therapeutics Ltd（CYYNF）價格
CYYNF 股價走勢圖
CYYNF 收益
Cynata Therapeutics Ltd
$0.15
0%
$0
收盤價：Jan 16, 16:00:00 GMT-5
$0.15
0%
$0
盤後：Jan 16, 20:00:00 GMT-5
關鍵數據
前收市價
$0.15
開盤價
$0.15
當日範圍
$0.11 - $0.15
52週區間
$0.08 - $0.15
交易量
220
平均成交量
32
每股盈餘 (TTM)
-0.03
股息收益率
--
市值
$35.6M
什麼是 CYYNF？
Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The firm is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells (iPSCs) to manufacture cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale. Its product candidates include CYP-001, CYP-004 and CYP-006TK. CYP-001 is under Phase II clinical trials with a focus on treatment for steroid-resistant acute graft versus host disease (GvHD) and a Phase 1/II trial in patients undergoing kidney transplantation. CYP-006TK is a Cymerus iPSC-derived MSC topical wound dressing product candidate. This product is used in the Company’s Phase I clinical trial in diabetic foot ulcers (DFU). CYP-004, is an iPSC-derived MSC product for intra-articular injection (injection into a joint), is ongoing with a Phase III trial in patients with osteoarthritis of the knee.